Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19

Maximilian F. Konig, Alfred H.J. Kim, Marc H. Scheetz, Elizabeth R. Graef, Jean W. Liew, Julia Simard, Pedro M. MacHado, Milena Gianfrancesco, Jinoos Yazdany, Daman Langguth, Philip C. Robinson

Research output: Contribution to journalLetterpeer-review

23 Scopus citations
Original languageEnglish
Pages (from-to)1386-1388
Number of pages3
JournalAnnals of the Rheumatic Diseases
Volume79
Issue number10
DOIs
StatePublished - Oct 1 2020

Keywords

  • epidemiology
  • hydroxychloroquine
  • lupus erythematosus
  • pharmacokinetics
  • systemic

Cite this